The Growing Demand for ERCP: Key Trends and Market Insights

By -

The global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is witnessing substantial growth due to the increasing prevalence of pancreatic and biliary disorders. In 2024, the market was valued at USD 1.72 billion, and it is projected to reach USD 3.41 billion by 2032, growing at a CAGR of 8.92% during the forecast period.

ERCP is a vital minimally invasive procedure that helps in diagnosing and treating conditions affecting the bile and pancreatic ducts. It is commonly used for managing gallstones, bile duct strictures, pancreatic cancer, and other related disorders. With the rising incidence of these conditions, the demand for advanced diagnostic and therapeutic solutions continues to surge.



Technological Advancements Fuel Market Growth

One of the key drivers of the ERCP market is technological innovation. The introduction of AI-powered endoscopic imaging, improved duodenoscopes, advanced guidewires, and precision sphincterotomes has significantly enhanced the accuracy, safety, and efficacy of ERCP procedures. These innovations help in early disease detection and better treatment planning, reducing patient recovery time.

Post-Pandemic Market Recovery

Although the COVID-19 pandemic temporarily impacted ERCP procedures due to restrictions on elective treatments, the market has rebounded. With increasing awareness of early disease detection and growing acceptance of minimally invasive procedures, the ERCP market is regaining momentum worldwide.

Regional Insights

  • North America dominates the ERCP market, driven by advanced healthcare infrastructure, high prevalence of pancreatic diseases, and key industry players.

  • Asia-Pacific is the fastest-growing region, thanks to rising healthcare investments, improving medical access, and increasing awareness of gastrointestinal disorders.

Comments

Post a Comment

Popular posts from this blog

How the Patient Handling Equipment Market Has Witnessed Substantial Growth in Coming Years?

By -
Image
A report by the United Nations Department of Economic and Social Affairs said that the global population of people in the 60 and above age group is rising rapidly. By the end of 2050, the global share of this age group is expected to grow to 21.1% from 11.7% in 2013. Additionally, the number of people in this age group is predicted to be around 324 million in India, 437 million in China, 58 million in Brazil, and 107 million in the U.S. by 2050. One of the major contributors of the growing elderly population is the increasing life expectancy rate.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/patient-handling-equipment-market/report-sample Taking care of the bed-ridden patients or patients with restricted mobility can be taxing for caregivers. They have to perform many tasks, such as lifting, transferring them from one place to another, repositioning, bathing, and dressing a patient. Manual lifting of patients is one of the major risk factors...
Read more

Endoscope Reprocessing Market Size, Business Opportunities and Top Manufacture

By -
Image
 In 2021, the global endoscope reprocessing market was worth around $1,879.9 million, and it is predicted to hit $4,358.1 million by 2030, progressing at a 9.8% CAGR from 2021 to 2030. This is primarily due to the growing preference for minimally invasive treatments, increasing danger of infection by contaminated endoscopes, and rising stringency of the rules governing medical device safety on a global scale. To avoid the complications and extra costs related to the different services offered under contracts with medical equipment manufacturers, end users are increasingly entering into multi-vendor contracts with ISOs. For example, customers may combine all of NovaMed Corporation's services under a single contract, owing to its extensive service management program. With an estimated contribution of $1.0 billion, North America leads the endoscope reprocessing market. This is due to the region's advantageous reimbursement policies, increase in cancer incidence, and demand for les...
Read more

Why are Medical Device Manufacturers Outsourcing Product Manufacturing Processes?

By -
Image
With the rising incidence of chronic diseases and the surging healthcare expenditure of several countries, the demand for medical devices is shooting up across the world. For instance, according to the World Health Organization (WHO), cancer caused the deaths of 9.6 million people in 2018 and it was the second biggest cause of death across the world. Furthermore, the organization found the around 422 million people around the world are living with diabetes, and the disease is responsible for 1.6 million deaths every year.  Additionally, as per an article published in the Cardiac Failure Review, 5.7 million heart failures were reported in the U.S. in 2016, and this number is expected to rise to 8 million by 2030. As a result of the rising incidence of these diseases, many medical device manufacturers are outsourcing the production processes as it helps them reduce cost and save time. Moreover, in order to manage maintenance and quality control, medical device manufacturers are outso...
Read more